← All Sponsors
SPONSOR

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Total Trials
12
Recruiting
12
Phases
EARLY_Phase 1, Phase 4, Phase 1, Phase 2

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology is a clinical research sponsor with 12 registered studies on ClinicalTrials.gov, of which 12 are actively recruiting participants. Research covers conditions including B-cell Non-Hodgkin Lymphoma (B-NHL), System Lupus Erythematosus(SLE), Scleroderma, Myasthenia Gravis (MG).

The trial portfolio spans EARLY_Phase 1, Phase 4, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

How many clinical trials has Union Hospital, Tongji Medical College, Huazhong University of Science and Technology sponsored?
ClinicalMetric currently tracks 12 clinical trials sponsored by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, of which 12 are actively recruiting participants. These trials cover conditions including B-cell Non-Hodgkin Lymphoma (B-NHL), System Lupus Erythematosus(SLE), Scleroderma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Union Hospital, Tongji Medical College, Huazhong University of Science and Technology research focus on?
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology clinical trials span B-cell Non-Hodgkin Lymphoma (B-NHL), System Lupus Erythematosus(SLE), Scleroderma, Myasthenia Gravis (MG), Bronchiectasis, and additional conditions. The research pipeline includes EARLY_Phase 1, Phase 4, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Union Hospital, Tongji Medical College, Huazhong University of Science and Technology clinical trial?
To participate in a Union Hospital, Tongji Medical College, Huazhong University of Science and Technology trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Union Hospital, Tongji Medical College, Huazhong University of Science and Technology trials with current recruitment status updated daily.

Clinical Trials by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

NCT06693973 EARLY_Phase 1
Recruiting

An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

B-cell Non-Hodgkin Lymphoma (B-NHL)
NCT07470151
Recruiting

Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases

System Lupus Erythematosus(SLE)
NCT06344000
Recruiting

Study on Disease Progression and Nutritional Status in Bronchiectasis

Bronchiectasis
NCT06653556 EARLY_Phase 1
Recruiting

A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE)
NCT07118813
Recruiting

Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment

Renal Cell Carcinoma (Kidney Cancer)
NCT07092202 Phase 4
Recruiting

Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC With Leptomeningeal Metastases

Leptomeningeal Metastasis
NCT07240974 EARLY_Phase 1
Recruiting

Safety and Efficacy of ZZSW-01 in Relapsed/Refractory B-cell Malignancies

Relapsed/Refractory B-cell Malignancies
NCT06907927
Recruiting

Using Artificial Intelligence to Improve Radiologists' Performance in Radiology Report Writing: a Randomised Controlled Trial

Healthy
NCT06349343 Phase 1
Recruiting

CD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
NCT06290661
Recruiting

Clinical Trial of the Safety and Efficacy of Peripheral Nerve Stimulation in the Treatment of Peripheral Neuropathic Pain.

Postherpetic Neuralgia
NCT05614050
Recruiting

The Prognosis of Patients After PCI:a Multi-center Study in China

Inflammation
NCT06234007 Phase 2
Recruiting

Short-course Radiotherapy Followed by Fruquintinib Plus Adebrelimab and CAPOX in the Full Course Neoadjuvant Treatment of Locally Advanced Rectal Cancer: a Multicenter, Single-arm, Open-label Study

Locally Advanced Rectal Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology